Do you want to take position on the Lonza share price online or simply buy this stock in order to add it to your stock portfolio? In this case, you must make sure that you have all the necessary elements to implement your analyses of this stock. We offer our help in this complex task by providing you with a summary of all the data you will need. We'll be taking a look at the fundamental analysis of the company, its main and secondary activities, its main direct competitors and even its most recent strategic allies.
First of all, attention should be paid to the research and development activities of the Lonza company with the aim of creating and bringing new products to the market and meet more of the needs of its customers.
The increasingly stringent regulations regarding the environmental impact of chemicals and their use in everyday products also need to be closely monitored for their possible impact on Lonza's activities.
You can also take an interest in the operations set up by Lonza aimed at supporting its growth with merger or acquisition strategies and the implementation of large-scale partnerships in research or commercialization.
Finally, we suggest you follow all the official communications of the group concerning its growth strategies, its long-term plans and of course the publication of its annual and quarterly results.
Learn a little more about the Lonza Company with a detailed presentation, especially of its main activities. As a result, you'll know the different sources of income of the company and will be able to anticipate its most important issues.
The Lonza group is a Swiss company operating in the chemicals sector. More specifically, the group is one of the world leaders in the development, manufacture and marketing of chemicals.
To better understand the group's activities, they can be divided into several divisions according to the percentage of turnover they generate as so:
It's also interesting to know the geographical distribution of the Lonza group. It realizes 9.7% of its turnover in Switzerland, 28.3% in Europe, 42.3% in the United States, 3.8% in America, 14.2% in Asia, 13.3% in Australia and New Zealand, 0.3% in Africa and 0.1% in the rest of the world.
Now let's find out who Lonza's main competitors are in the market with a presentation of the major companies in this sector:
The French group Arkema is of course a giant in the chemicals sector and is particularly known for the specialty chemicals and performance materials it develops. This company operates in over 55 countries around the world and as such employs more than 20,500 people.
this German pharmaceutical company has also specialized in agrochemicals since its takeover of Monsanto a few years ago. Bayer particularly specializes in the design and development of medicines, non-prescription health products, veterinary products and phytosanitary products intended primarily for agriculture.
Finally, there is also competition from the Swiss giant Nestlé, which is one of the leaders in the agrifood industry worldwide. It is also the world's leading agrifood company and the largest dairy company. But Nestlé also produces nutritional ingredients, which puts it in direct competition with Lonza.
Let's check out two strategic partnerships that the Lonza group has set up with other companies and which have enabled its stock market to gain points quickly.
In 2020, the Lonza group signed a partnership with HES-SO Valais-Wallis with the aim of building common skills in the training and research sector.
In 2019, the Sanofi group announced a strategic partnership with Lonza in the construction and operation of a large-scale mammalian cell culture facility in Switzerland dedicated to the production of monoclonal antibodies. The initial investment of this partnership was 290 million Swiss francs or 270 million euros and shared equally between the two partners.
In order to understand how Lonza's growth is likely to behave in the longer or shorter term, it is necessary to know what its main strengths and weaknesses are, which represent both advantages and disadvantages for this stock. This is why we propose to discover here what are the strong and weak points of this stock at the moment.
Let's start this comparative analysis of Lonza's strengths and weaknesses by summarising its main strengths:
Now that we have covered the main strengths of the Lonza Group, it is necessary to know its weaknesses as well. Because the company also has its weaknesses, which represent as many disadvantages for this stock on the stock market:
The Lonza group is established all over the world through various subsidiaries that it operates and that it has either developed or acquired. These include the Lonza subsidiary in the United States, the Lonza subsidiary in the United Kingdom, the Lonza subsidiary in Canada and the Lonza subsidiary in Germany. The group has decided to keep its own name for all its subsidiaries for reasons of consistency and brand image.
The capital of Lonza is 4.58% owned by Fidelity Management & Research, 3.24% by BlackRock Investment Management, 3.02% by Artisan Partners, 2.97% by UBS Asset Management Switzerland, 2.75% by The Vanguard Group, 2.54 % to Templeton Global Advisers, 2.33% to Norges Bank Investment Management, 2.13% to Schroder Investment Management and 1.79% to Zurcher Kantonalbank Investment Management. The rest of the company's capital is floating.
If you want to consult the financial results of the Lonza group, whether it is annual or quarterly results, you can find them easily online. To do so, you can go to the company's website in the dedicated section. You can also find this data on websites specializing in economics and finance or from your broker.
eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. {etoroCFDrisk}% of retail CFD accounts lose money. You should consider whether you can afford to take the high risk of losing your money.
Past performance is not an indication of future results. Trading history presented is less than 5 complete years and may not suffice as basis for investment decision.
Copy trading is a portfolio management service, provided by eToro (Europe) Ltd., which is authorised and regulated by the Cyprus Securities and Exchange Commission.
Cryptoasset investing is unregulated in some EU countries and the UK. No consumer protection. Your capital is at risk.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro.
